跳到主要内容

STERIS plc (STE) Stock Forecast 2025 - AI Price Prediction & Analysis


STERIS plc (STE) AI Stock Price Forecast & Investment Analysis

STERIS plc Stock Price Chart and Technical Analysis

Loading STERIS plc interactive price chart and technical analysis...

STERIS plc (STE) - Comprehensive Stock Analysis & Investment Research

Deep dive into STERIS plc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about STERIS plc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For STERIS plc: STERIS plc operates in the Industrial Applications and Services sector, positioning it as a large-cap market leader.

STERIS plc (Stock Symbol: STE) is a leading company in the Industrial Applications and Services sector , specifically operating within the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.

The organization employs approximately 6812 professionals worldwide .

The company has established itself as a major market leader with significant institutional backing.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing STERIS plc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For STERIS plc: With $5571M in annual revenue and 9.2% net margin, the company demonstrates solid profitability.

Annual Revenue: $5571 million generating a 9.2% net profit margin .

Market Capitalization: $24135 million - Classified as a large-cap stock with institutional-grade stability.

Return on Equity (ROE): 4.7% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for STERIS plc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For STERIS plc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for STERIS plc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: STERIS plc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For STERIS plc: Strong free cash flow generation demonstrates solid operational efficiency.

STERIS plc strategically competes in the highly dynamic Orthopedic, Prosthetic & Surgical Appliances & Supplies marketplace, positioning itself as a dominant large-cap market leader with significant competitive moats and institutional investor confidence .

The company demonstrates robust operational efficiency through strong free cash flow generation of $397 million annually, complemented by impressive 16.8% year-over-year cash flow growth.

The company maintains a healthy 43.4% gross margin, indicating strong pricing power and operational efficiency.

STERIS plc (STE) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for STERIS plc stock analysis.

Loading STERIS plc comprehensive fundamental analysis and insider trading data...

Deep dive into STERIS plc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if STERIS plc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For STERIS plc: With a P/E ratio of 37.32, the market highly values future growth prospects.

P/E Ratio 37.32x
P/B Ratio 3.47x
Market Cap $24135M
Dividend Yield 0.94%
EPS $6.57
Book Value/Share $70.29
Revenue/Share $56.28
FCF/Share $5.54
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently STERIS plc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For STERIS plc: An ROE of 4.7% indicates room for improvement in shareholder value creation.

ROE 4.7%
ROA 2.7%
ROIC 4.0%
Gross Margin 43.4%
Operating Margin 17.6%
Net Margin 9.2%
EBT Margin 6.9%
Tax Rate 22.8%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess STERIS plc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For STERIS plc: A current ratio of 2.04 indicates strong liquidity.

Current Ratio 2.04x
Quick Ratio 1.24x
D/E Ratio 0.47x
Financial Leverage 1.75x
Interest Coverage 4.5x
Working Capital $634M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal STERIS plc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For STERIS plc: Free cash flow of $397M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $685M
Free Cash Flow $397M
Capital Spending $-288M
OCF Growth YoY 16.8%
FCF Growth YoY 19.8%
FCF/Sales 8.7%
CapEx/Sales 6.3%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively STERIS plc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For STERIS plc: An asset turnover of 0.51x suggests room for improvement in asset utilization.

Asset Turnover 0.51x
Receivables Turnover 6.5x
Inventory Turnover 5.8x
Fixed Assets Turnover 2.9x
Days Sales Outstanding 56 days
Days Inventory 63 days
Payables Period 27 days
Cash Conversion Cycle 92 days
Understanding Financial Statement Data

What these metrics mean: Key figures from STERIS plc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For STERIS plc: With annual revenue of $5571M, STERIS plc operates at significant scale.

Income Statement ($ Millions)
Total Revenue $5571M
R&D Expense $105M
SG&A Expense $33M
Cost of Goods Sold $639M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 16%
Cash & Short-term Investments 3%
Total Liabilities 43%
Short-term Debt 1%
Accounts Receivable 7%
Inventory 5%
Dividend & Shareholder Information
Dividends Per Share $2.28
Payout Ratio 0.4%
Shares Outstanding 99M
Growth Metrics (YoY)
EPS Growth 2.1%

Latest STERIS plc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting STERIS plc (STE) stock price and investment outlook.

, source: Insider Monkey

The London Company, an investment management company, released “The London Company Mid Cap Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. During 4Q, U.S.

, source: Crain's Cleveland Business

Two subsidiaries of Steris Plc (NYSE: STE), the Dublin, Ireland-based maker of sterilization products with U.S. operations headquartered in Mentor, have agreed to sell Steris' renal care business to ...

, source: Yahoo Finance

Full year fiscal 2025 revenue from continuing operations increased 6%; constant currency organic revenue growth was 6% Full year fiscal 2025 as reported diluted EPS from continuing operations ...

STERIS plc Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of STERIS plc against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ALGN Unlock Forecast - 30 Days FREE Trial $9718M 22.2x 2.5x
APT Unlock Forecast - 30 Days FREE Trial $51M 14.4x 0.8x
AVNS Unlock Forecast - 30 Days FREE Trial $589M 100.0x 0.8x
AVR Unlock Forecast - 30 Days FREE Trial $148M x 6.1x
BBLG Unlock Forecast - 30 Days FREE Trial $9M -0.6x 3.2x
BBLGW Unlock Forecast - 30 Days FREE Trial $49M -9.0x 16.9x
CDRE Unlock Forecast - 30 Days FREE Trial $1276M 33.5x 3.8x
CLGN Unlock Forecast - 30 Days FREE Trial $35M x 2.8x
COCH Unlock Forecast - 30 Days FREE Trial $7M -4.5x -0.3x
COCHW Unlock Forecast - 30 Days FREE Trial $1M x -0.1x
ENOV Unlock Forecast - 30 Days FREE Trial $1784M -23.9x 0.7x
ESTA Unlock Forecast - 30 Days FREE Trial $1091M -15.4x 47.9x
EW Unlock Forecast - 30 Days FREE Trial $46288M 11.2x 4.4x
HSCS Unlock Forecast - 30 Days FREE Trial $3M -0.3x 0.7x
HSCSW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
INGN Unlock Forecast - 30 Days FREE Trial $219M -2.8x 1.1x
ISRG Unlock Forecast - 30 Days FREE Trial $164960M 63.3x 9.2x
LAKE Unlock Forecast - 30 Days FREE Trial $143M 742.3x 1.0x
LFWD Unlock Forecast - 30 Days FREE Trial $8M -2.5x 0.6x
LGMK Unlock Forecast - 30 Days FREE Trial $3M -0.3x 0.1x
MLSS Unlock Forecast - 30 Days FREE Trial $49M -7.1x 14.6x
MNESP Unlock Forecast - 30 Days FREE Trial $M x x
MSA Unlock Forecast - 30 Days FREE Trial $6875M 25.8x 8.4x
MYO Unlock Forecast - 30 Days FREE Trial $41M -26.3x 2.4x
NAOV Unlock Forecast - 30 Days FREE Trial $4M -0.5x 0.1x
NTRB Unlock Forecast - 30 Days FREE Trial $90M -5.1x 17.7x
NTRBW Unlock Forecast - 30 Days FREE Trial $26M -2.3x 5.2x
POAI Unlock Forecast - 30 Days FREE Trial $9M -2.5x -48.4x
RBOT Unlock Forecast - 30 Days FREE Trial $34M -4.2x 1.5x
SMTI Unlock Forecast - 30 Days FREE Trial $299M -37.5x 8.4x
SPAI Unlock Forecast - 30 Days FREE Trial $104M x 40.4x
STE Unlock Forecast - 30 Days FREE Trial $24135M 37.3x 3.5x
ZBH Unlock Forecast - 30 Days FREE Trial $20373M 24.7x 1.6x

Frequently Asked Questions - STERIS plc Stock Forecast

How accurate are STERIS plc stock predictions?

Our AI model demonstrates 51% historical accuracy for STE predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence STERIS plc stock price forecasts?

Our analysis considers STERIS plc's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is STERIS plc a good investment in 2025?

Based on our AI analysis, STERIS plc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are STERIS plc forecasts updated?

STERIS plc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced STERIS plc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for STERIS plc stock.

My Portfolio

Investment Dashboard

Loading your portfolio...